Suchergebnisse - "Doehn, Christian"

PubPharm (4)

1

Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma : Final Overall Survival Analysis of the Phase 3 PROTECT Trial

enthalten in: European urology | 2021

von Motzer, R. | Russo, P. | Haas, N. | +22

CommentIn: Eur Urol. 2021 Jul;80(1):e33-e34. - PMID 33962807

2

Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Sternberg, C. | Donskov, F. | Haas, N. | +7

CommentIn: Clin Cancer Res. 2018 Jul 1;24(13):2979-2980. - PMID 29523625

3

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Motzer, R. | Haas, N. | Donskov, F. | +23

CommentIn: J Clin Oncol. 2017 Dec 10;35(35):3895-3897. - PMID 29068785

4

The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape

enthalten in: Future oncology (London, England) | 2017

von Goebell, P. | Doehn, C. | Grüllich, C. | +4

1
[1]